4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow Central Nervous System: new trials by email Literature Review of Central Nervous System trials Research Report on Central Nervous System
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets YZJ-1139 tablets, Escitalopram oxalate tablets, YZJ-1139 simulated tablets - Insomnia, Central Nervous System | Phase 1 | Completed | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | 24 | 2024-08-31 | 2026-06-30 |
| Xanamem™ in Healthy Elderly Subjects Xanamem, Matching Placebo - Safety, Peripheral Neuropathy | Phase 1 | Completed | Actinogen Medical | 42 | 2019-01-21 | 2025-01-22 |
| Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours Vinblastine, Temsirolimus - Recurrent Lymphoma, Refractory Lymphoma | Phase 1 | Completed | Canadian Cancer Trials Group | 7 | 2015-06-24 | 2023-08-04 |
| A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel alcohol + placebo, alcohol + perampanel, perampanel + alcohol - Central Nervous System | Phase 1 | Completed | Eisai Limited | 59 | 2010-05-01 | 2012-02-13 |
Lymphoma (1) · Peripheral Nervous System Diseases (1) · Sleep Initiation and Maintenance Disorders (1) · Small Fiber Neuropathy (1)
Nervous System Diseases (2) · Dyssomnias (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neuromuscular Diseases (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
Escitalopram (1) · Ethanol (1) · UE2343 (1) · Vinblastine (1) · perampanel (1) · temsirolimus (1)
Actinogen Medical (1) · Canadian Cancer Trials Group (1) · Eisai Limited (1) · Shanghai Haiyan Pharmaceutical Technology Co., Ltd. (1)
Australia (1) · Canada (1) · China (1) · United Kingdom (1)
Bill Ketelbey, MD (1) · Daryl Bendel (1) · Rebecca Deyell (1) · Sylvain Baruchel (1)